We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
AUM
$321M
AUM Growth
+$11.5M
Cap. Flow
+$16.1M
Cap. Flow %
5.01%
Top 10 Hldgs %
26.2%
Holding
358
New
36
Increased
93
Reduced
39
Closed
39

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$4.11M
2
GLW icon
Corning
GLW
+$4.02M
3
BAX icon
Baxter International
BAX
+$3.78M
4
BSX icon
Boston Scientific
BSX
+$3.65M
5
CSX icon
CSX Corp
CSX
+$3.5M

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Healthcare 13.54%
3 Financials 12.68%
4 Communication Services 10.01%
5 Consumer Staples 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLV icon
251
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$5K ﹤0.01%
41
-200
-83% -$26.4K
EXP icon
252
Eagle Materials
EXP
$6.67B
$4K ﹤0.01%
33
FATE icon
253
Fate Therapeutics
FATE
$303M
$4K ﹤0.01%
61
HUN icon
254
Huntsman Corp
HUN
$1.79B
$4K ﹤0.01%
150
LIN icon
255
Linde
LIN
$226B
$4K ﹤0.01%
14
NET icon
256
Cloudflare
NET
$105B
$4K ﹤0.01%
34
+4
+13% +$478
ROP icon
257
Roper Technologies
ROP
$39.1B
$4K ﹤0.01%
8
SHW icon
258
Sherwin-Williams
SHW
$88.8B
$4K ﹤0.01%
15
SHY icon
259
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$4K ﹤0.01%
46
TROW icon
260
T. Rowe Price
TROW
$24.7B
$4K ﹤0.01%
21
VWOB icon
261
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.18B
$4K ﹤0.01%
50
ABNB icon
262
Airbnb
ABNB
$90.4B
$3K ﹤0.01%
20
APD icon
263
Air Products & Chemicals
APD
$65.5B
$3K ﹤0.01%
13
ATHE
264
Alterity Therapeutics
ATHE
$79.2M
$3K ﹤0.01%
+200
New +$2.78K
BF.B icon
265
Brown-Forman Class B
BF.B
$13.1B
$3K ﹤0.01%
40
CB icon
266
Chubb
CB
$135B
$3K ﹤0.01%
17
CINF icon
267
Cincinnati Financial
CINF
$27.5B
$3K ﹤0.01%
28
CL icon
268
Colgate-Palmolive
CL
$73.8B
$3K ﹤0.01%
35
ECL icon
269
Ecolab
ECL
$80.2B
$3K ﹤0.01%
14
KHC icon
270
Kraft Heinz
KHC
$30.6B
$3K ﹤0.01%
77
-66
-46% -$2.48K
LYV icon
271
Live Nation Entertainment
LYV
$43B
$3K ﹤0.01%
31
MDT icon
272
Medtronic
MDT
$110B
$3K ﹤0.01%
25
MKC icon
273
McCormick & Company Non-Voting
MKC
$14.1B
$3K ﹤0.01%
36
PBI icon
274
Pitney Bowes
PBI
$2.52B
$3K ﹤0.01%
408
RBLX icon
275
Roblox
RBLX
$26.1B
$3K ﹤0.01%
35

Similar funds

Providence Capital Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Providence Capital Advisors held 358 positions worth $321M, up 3.7% from $309M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Providence Capital Advisors deployed $16.1M of net new capital in Q3 2021, opening 36 new positions and adding to 93 existing holdings. Its largest new stake was Boston Scientific: 82,600 shares worth $3.58M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $4.44M trimmed.

  • Providence Capital Advisors's largest Q3 2021 buy was Boston Scientific: 82,600 shares worth $3.58M.
  • Providence Capital Advisors added most to Starbucks in Q3 2021, an estimated $4.11M increase.
  • Providence Capital Advisors's biggest Q3 2021 reduction was Gilead Sciences, cutting an estimated $4.44M.
  • Providence Capital Advisors fully exited Johnson Controls International in Q3 2021, selling an estimated $3.69M.
  • Providence Capital Advisors's ten largest holdings make up 26% of its $321M portfolio in Q3 2021.
  • Providence Capital Advisors opened 36 new positions and closed 39 in Q3 2021.
  • Providence Capital Advisors's portfolio value rose 3.7% quarter-over-quarter to $321M.

Based on Providence Capital Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.